Filing Flows › Bio-Rad Laboratories (BIO) › Q2 2025
Bio-Rad Laboratories (BIO) Q2 2025 earnings results (second quarter 2025)
10-Q filed Jul 31, 2025
Bio-Rad Laboratories (BIO) reported revenue of $652M for the second quarter 2025 (Q2 2025), +2% from a year earlier and +11% from the quarter before. Operating margin was 11.8%, net earnings $318M (48.8% of revenue).
Bio-Rad Laboratories, Q2 2025: revenue $652M (+2% year over year), operating margin 11.8%, net earnings $318M, operating cash flow $116M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $652M | +11% | +2% |
| Gross profit | $345M | +13% | -3% |
| Operating profit | $77.1M | +225% | -24% |
| Net earnings | $318M | +397% | — |
| Operating cash flow | $116M | -10% | +19% |
| Free cash flow | $70.8M | -26% | +28% |
What changed
Revenue was $651.6M in Q2 2025, up 2% year over year and up 11% from the previous quarter. Clinical Diagnostics was the largest line at 60% of revenue. Life Science added $12.3M year over year (up 5%), 94% of the total change.
Gross margin was 53.0%, down 2.6 points from a year earlier. Operating profit was $77.1M, a 11.8% margin (down 4.1 points year over year). Operating profit fell $24.4M even though revenue rose $13.1M versus a year earlier, so costs grew faster than sales. Operating expenses grew 6% against revenue growth of 2%. Net earnings were $317.8M. The effective tax rate was 23.2%. Non-operating items added $336.9M, 81% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $116.5M (up 19% year over year), 37% of net earnings. Non-cash charges added back $11.9M of share-based compensation. Working capital and other items used $213.2M. Capital expenditures of $45.7M left free cash flow of $70.8M.
Questions
What was Bio-Rad Laboratories' revenue in the second quarter 2025?
Bio-Rad Laboratories (BIO) reported revenue of $652M for the second quarter 2025 (Q2 2025), +2% from a year earlier and +11% from the quarter before.
Was Bio-Rad Laboratories profitable in the second quarter 2025?
Operating profit was $77.1M (11.8% of revenue) and net earnings $318M.